SEC Form D private-offering filing

Metallomix, Inc

A new SEC Form D private-offering notice from Miami, FL, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Metallomix, Inc site↗ Verified via SEC Form D

Clinical stage biotechnology company developing isotope selective modulation therapies, including lead candidate KLS-1, to treat cancer and diseases of aging linked to isotopic dysfunction.

Filed 2025-11-10Filed to raise $10,000,000First money in 2021-10-18Raised so far $1,158,060HQ (as filed) Miami, FLSector Biotech Stage (inferred) EarlyCall status Late filing
Source linked the Form D on EDGAR↗Website verified metallomix.com↗Named in the filing 3 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.